MOTS-c
Also known as Mitochondrial ORF of the twelve S rRNA type-c, Mitochondrial derived peptide
Last reviewed · Awaiting clinical review
Main safety concerns
Almost all of the evidence is from animals and cells. Human data is limited, so treat any human benefits as unproven.
- SeriousAvoid if: Pregnancy or breastfeeding
- WarningUnknown long term risks, since there is no long term human safety data
Educational information, not medical advice. If you have symptoms that worry you, contact a clinician or emergency services.
What is known
A small mitochondrial peptide studied for energy metabolism, fat handling, and healthy aging.
On this page
What it is and how it works
MOTS-c is a short peptide encoded inside mitochondrial DNA, which makes it unusual. It acts like an energy signal. Its best studied effect is turning on AMPK, a master switch that tells cells to burn fat and handle glucose better, especially under stress, exercise, or aging. Because the body makes it naturally, it is often framed as a metabolism and longevity peptide.[1]
Evidence by claim
Each claim is graded on its own. Tap a grade to see what it does and does not mean.
Turns on AMPK and shifts cells toward burning fat and handling glucose better.
Source type: Review
Its most studied effect, shown in cell and animal work.
Improves metabolic health, exercise capacity, and markers of aging.
Source type: Review, Animal study
The preclinical findings are interesting, but human data is limited and still emerging.
Used by people for fat loss, energy, and longevity.
Community use runs ahead of the human evidence.
No source cited for this claim.
Reported side effects
Interactions and combination risks
- CautionBlood sugar lowering medicines
Because it may improve glucose handling, watch for additive effects if you already take diabetes medicine.
Who should avoid it
- SeriousPregnancy or breastfeeding
No safety data in pregnancy or breastfeeding.
Dosing
Placed after the evidence and risks on purpose. Nothing here is a recommendation for you.
| Route(s) | subcutaneous |
|---|---|
| Typical range | About 5 to 10 mg per week, often split as 5 mg two to three times a week. |
| Frequency | 2 to 3 times per week |
| Cycle guidance | Usually run in 4 to 8 week cycles. |
| Notes | Human dosing comes from community practice, not trials. Animal data points to a short blood , roughly 1 to 2 hours, so MOTS-c does not build up in the blood. The spread out schedule reflects how long its effects seem to last, not how long it stays in the blood. |
For the equipment itself, see syringes, needles, and the rest of the kit.
Reconstitution
| Vial sizes | 5 mg, 10 mg |
|---|---|
| Diluent | Bacteriostatic water for multi dose vials, or sterile water for single use |
| Concentration | Example: a 10 mg vial plus 1 mL of water gives 10 mg/mL, so a 5 mg dose is 0.5 mL, which is 50 units on a U-100 syringe. Add more water for a smaller draw. |
| Notes | MOTS-c usually ships as 5 mg or 10 mg freeze dried vials. |
General reconstitution technique
Units and volume arithmetic
Converts between an amount and syringe units for the vial and diluent you enter. It starts empty and does not suggest an amount. Open the full calculator
Result
Fill in steps 1 to 3 to see the arithmetic. Nothing here is a suggested amount.
Settings live in the address bar, so a pasted link reopens this calculator as you left it.
Educational arithmetic only. It does not choose an amount for you and is not medical or dosing advice. Verify every calculation independently.
Storage and stability
Dry powder (lyophilized)
| Temperature | Freeze for long term storage, or 2 to 8 short term |
|---|---|
| Shelf life | Many months when frozen |
| Notes | Keep dry and out of light until you mix it. |
After mixing
| Temperature | 2 to 8 (refrigerated) |
|---|---|
| Shelf life | About 2 to 4 weeks |
| Notes | Do not freeze after mixing. Discard if cloudy or discolored. |
COA and purity notes
| Common adulterants | underdosed or mislabeled vials, material sold with poor stability, since these peptides degrade easily |
|---|---|
| Mislabeling | Mitochondrial peptides are fragile and can degrade, so storage and a recent COA matter. |
| Notes | Sold as unregulated research material. |
Sources
[1]MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism
PMC (peer reviewed review) 2016 (opens source in a new tab)· Review[2]MOTS-c restores mitochondrial respiration in the type 2 diabetic heart
PMC (preclinical study) 2025 (opens source in a new tab)· Animal study[3]FDA Briefing Document, Pharmacy Compounding Advisory Committee, July 23 to 24, 2026: MOTS-c Related Bulk Drug Substances
U.S. Food & Drug Administration 2026 (opens source in a new tab)· Regulatory record[4]Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
U.S. Food & Drug Administration 2026 (opens source in a new tab)· Regulatory record[5]World Anti-Doping Code International Standard: Prohibited List 2026
World Anti-Doping Agency (WADA) 2026 (opens source in a new tab)· Regulatory record
Last reviewed 8 July 2026 · editorial status: reviewed